Nexgel (NXGLW) Stock: Why It's Up Today
Updated Oct 19, 2026, 12:05 PM ET · intraday price
- Trading at $0.01 as of 12:05 PM ET, +1.01% vs the prior close of $0.01.
- Volume 234.67K shares, 3.5x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NXGLW rises 1.0% to $0.01 on 3.5x normal volume. Trading at $0.01 (intraday, 12:05 PM ET), +1.01% vs the prior close of $0.01. Day range $0.01–$0.01, opened at $0.31.
NXGLW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — NXGLW rises 1.0% to $0.01 on 3.5x normal volume
- Trading at $0.01 (intraday, 12:05 PM ET), +1.01% vs the prior close of $0.01. Day range $0.01–$0.01, opened at $0.31.
- Volume was 234.67K shares, 3.5x its 50-day average of 66.74K — unusually heavy trading.
- 52-week range $0.01–$0.01; the current price sits at 100% of that range, at a new 52-week high.
NXGLW bull case vs bear case (from the data)
- Annual revenue grew 31.5% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: loss of $3.00M.
- Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
- Share count up 20.8% in a year (dilution).
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
NXGLW latest news & SEC filings
Every SEC filing by or about NXGLW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Sep 30, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 24, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 20, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 17, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $3.69M (prior year $2.88M) (+27.8% vs Jun 30, 2025)
- Net income: -$3.63M (prior year -$665.00K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.40 (prior year -$0.09) (loss widened vs Jun 30, 2025)
Aug 17, 2026 · Form NT 10-Q — Notice of late quarterly report
Notice of late quarterly report
Aug 14, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade NXGLW
- Last results release: Aug 17, 2026 (8-K Item 2.02). Previous ones: Nov 12, 2025, Aug 12, 2025, May 13, 2025. Based on that rhythm, the next report is likely around Nov 16, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.01% (largest 1.0%).
- Liquidity: about 150.71K shares (≈$1.51K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.01 vs a range of $0.01–$0.01 (100% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Adam R. Levy sold 5,000 shares on Jun 23, 2026.
- Latest filings: 8-K Oct 7, 2026; 8-K Sep 24, 2026; 8-K Sep 23, 2026.
- Share count: 9.75M shares outstanding (Aug 14, 2026), +20.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
NXGLW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.31 | 0.01 | 0.01 | 0.01 | 234.67K |
| Oct 16, 2026 | 0.31 | 0.01 | 0.01 | 0.01 | 66.74K |
About Nexgel
Nexgel (NXGLW) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in LANGHORNE, PA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1468929.
NXGLW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kevin Mcclain Harris | Director | May 18, 2026 |
| Scott Robert Henry | Director | May 18, 2026 |
| Brian Joseph Kieser | Director | May 18, 2026 |
| Adam R. Levy | Chief Executive Officer | Jul 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ian Howard Blackman | Chief Financial Officer | May 7, 2026 |
| Adam R. Levy | Chief Executive Officer | Jul 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 23, 2026 | Adam R. Levy | Sale | 5,000 | $0.59 |
| Jun 23, 2026 | Adam R. Levy | Sale | 5,000 | $0.59 |
| Jun 23, 2026 | Adam R. Levy | Sale | 5,000 | $0.59 |
| Jun 23, 2026 | Adam R. Levy | Sale | 5,000 | $0.59 |
| Jun 18, 2026 | Adam R. Levy | Sale | 6,000 | $0.59 |
| Jun 18, 2026 | Adam R. Levy | Sale | 6,000 | $0.59 |
| Jun 18, 2026 | Adam R. Levy | Sale | 6,000 | $0.59 |
| Jun 18, 2026 | Adam R. Levy | Sale | 6,000 | $0.59 |
| Jun 11, 2026 | Adam R. Levy | Sale | 3,000 | $0.61 |
| Jun 11, 2026 | Adam R. Levy | Sale | 3,000 | $0.61 |
| Jun 11, 2026 | Adam R. Levy | Sale | 3,000 | $0.61 |
| Jun 11, 2026 | Adam R. Levy | Sale | 3,000 | $0.61 |
| Jun 8, 2026 | Adam R. Levy | Sale | 3,000 | $0.55 |
| Jun 8, 2026 | Adam R. Levy | Sale | 3,000 | $0.55 |
| Jun 8, 2026 | Adam R. Levy | Sale | 3,000 | $0.55 |
NXGLW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $11.42M | $-3.00M | -0.38 | $-1.31M |
| Dec 31, 2024 | $8.69M | $-3.28M | -0.50 | $-3.87M |
| Dec 31, 2023 | $4.09M | $-3.16M | -0.56 | $-3.24M |
| Dec 31, 2022 | $2.05M | $-4.75M | -0.85 | $-2.99M |
| Dec 31, 2021 | — | $-4.31M | -1.45 | $-2.75M |
Latest balance sheet: total assets $26.45M, total liabilities $20.98M, cash $938.00K (as of Jun 30, 2026).
NXGLW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 17, 2026 | 8-K Item 2.02 (results) | — |
| Nov 12, 2025 | 8-K Item 2.02 (results) | — |
| Aug 12, 2025 | 8-K Item 2.02 (results) | — |
| May 13, 2025 | 8-K Item 2.02 (results) | — |
| Mar 24, 2025 | 8-K Item 2.02 (results) | — |
| Jan 22, 2025 | 8-K Item 2.02 (results) | — |
| Nov 14, 2024 | 8-K Item 2.02 (results) | — |
| Oct 10, 2024 | 8-K Item 2.02 (results) | — |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| Jul 8, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)MiniMed (MMED)Medline (MDLN)Becton Dickinson (BDX)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on NXGLW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.